Undisclosed investigational product

· Nobelpharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Undisclosed investigational product, covering 2024-06-28 to 2024-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection [Phase 2]